Although noncontiguous CD4+ T cell epitopes had not previously been described in any disease, since 2004 there have been several reports of noncontiguous epitopes generated by the proteasome and recognized by tumor-reactive cytotoxic CD8+ T cells isolated from cancer patients (53, 54, 55, 56, 57). This evidence concerns the gene CD4 and cancer.